Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1

被引：84

作者：

Stephenson, Iain ^{[1
]}

Nicholson, Karl G. ^{[1
]}

Hoschler, Katja ^{[2
]}

Zambon, Maria C. ^{[2
]}

Hancock, Kathy ^{[3
]}

DeVos, Joshua ^{[3
]}

Katz, Jacqueline M. ^{[3
]}

Praus, Michaela ^{[4
]}

Banzhoff, Angelika ^{[4
]}

机构：

[1] Univ Hosp Leicester, Leicester LE1 5WW, Leics, England

[2] Hlth Protect Agcy, Colindale NW9 5HT, England

[3] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA

[4] Novartis Vaccine, D-35041 Marburg, Germany

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2008年 / 359卷 / 15期

基金：

英国医学研究理事会;

关键词：

D O I：

10.1056/NEJMc0805274

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1631 / 1633

页数：3

共 5 条

[1] Establishment of multiple sublineages of H5N1 influenza virus in Asia: Implications for pandemic control [J].

Chen, H ;

Smith, GJD ;

Li, KS ;

Wang, J ;

Fan, XH ;

Rayner, JM ;

Vijaykrishna, D ;

Zhang, JX ;

Zhang, LJ ;

Guo, CT ;

Cheung, CL ;

Xu, KM ;

Duan, L ;

Huang, K ;

Qin, K ;

Leung, YHC ;

Wu, WL ;

Lu, HR ;

Chen, Y ;

Xia, NS ;

Naipospos, TSP ;

Yuen, KY ;

Hassan, SS ;

Bahri, S ;

Nguyen, TD ;

Webster, RG ;

Peiris, JSM ;

Guan, Y .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (08) :2845-2850

[2] Strategies for mitigating an influenza pandemic [J].

Ferguson, Neil M. ;

Cummings, Derek A. T. ;

Fraser, Christophe ;

Cajka, James C. ;

Cooley, Philip C. ;

Burke, Donald S. .

NATURE, 2006, 442 (7101) :448-452

[3] Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza [J].

Nicholson, KG ;

Colegate, AE ;

Podda, A ;

Stephenson, I ;

Wood, J ;

Ypma, E ;

Zambon, MC .

LANCET, 2001, 357 (9272) :1937-1943

[4] Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population [J].

Stephenson, I ;

Nicholson, KG ;

Colegate, A ;

Podda, A ;

Wood, J ;

Ypma, E ;

Zambon, M .

VACCINE, 2003, 21 (15) :1687-1693

[5] Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers [J].

Stephenson, Iain ;

Zambon, Maria C. ;

Rudin, Anna ;

Colegate, Anthony ;

Podda, Audino ;

Bugarini, Roberto ;

del Giudice, Giusseppe ;

Minutello, Ada ;

Bonnington, Susan ;

Holmgren, Jan ;

Mills, Kingston H. G. ;

Nicholson, Karl G. .

JOURNAL OF VIROLOGY, 2006, 80 (10) :4962-4970

← 1 →